Statistics for Pharming Group N.V. (id:68 PHARM)
Valuation metrics
Market cap
597.29M
Enterprise value
380.87M
Trailing P/E (ttm)
57.15
Forward P/E
-88.05
PEG ratio
-88.05
Price/Sales (ttm)
2.09
Price/Book (mrq)
2.01
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
-130.15
Overview
Shares outstanding
678.35M
Float
500.40M
Shares short
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
12.85M
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
1.22
52-Week change
-17.24%
Beta
3.00
50-Day moving average
3.00
200-Day moving average
3.00
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
March 5, 2013
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-6.24%
Operating margin
5.49%
Operational effectiveness
Return on assets
-1.38%
Return on equity
-8.18%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
220.10M
EBITDA
-2,926,359.00
Net income to common (ttm)
-17,061,334.00
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
164.43M
Total cash per share (mrq)
3.00
Total debt (mrq)
121.65M
Total Debt/Equity (mrq)
56.28
Current ratio (mrq)
353.50%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
431.73K
Levered free cash flow (LFCF)
4.30M